Article Information
History
- September 20, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Stephanie L Battle1,#,
- Yun Soo Hong1,#,
- Wen Shi1,
- Daniela Puiu2,
- Vamsee Pillalamarri1,
- Nathan Pankratz3,
- Nicole J Lake4,5,
- Monkol Lek4,
- Eliseo Guallar6 and
- Dan E Arking1,*
- 1McKusick-Nathans Institute, Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 2Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA
- 3Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA
- 4Department of Genetics, Yale School of Medicine, New Haven, CT, USA
- 5Murdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne, Victoria, Australia
- 6Departments of Epidemiology and Medicine, and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, 21205, USA
- ↵*Corresponding author. Correspondence and requests for materials should be addressed to Dan E. Arking. Dan E. Arking, McKusick-Nathans Institute, Department of Genetic Medicine, Johns Hopkins University School of Medicine, 733 N. Broadway, Miller Research Building, Room 459, Baltimore, MD 21205, arking{at}jhmi.edu
↵# These authors contributed equally.
Posted September 20, 2022.
Deleterious heteroplasmic mitochondrial mutations increase risk of overall and cancer-specific mortality
